{
  "ticker": "JNJ",
  "target_date": "2024-12-18",
  "actual_date": "2024-12-18",
  "collected_at": "2025-12-08T11:09:51.818089",
  "price": {
    "open": 141.35,
    "high": 142.38,
    "low": 140.37,
    "close": 140.45071411132812,
    "volume": 9336100,
    "change_1d_pct": -1.13,
    "change_7d_pct": -3.24,
    "change_30d_pct": -7.86
  },
  "technicals": {
    "rsi_14": 18.88,
    "sma_20": 146.0,
    "sma_50": 150.47,
    "macd": -2.714,
    "macd_signal": -2.296,
    "macd_histogram": -0.418,
    "bb_upper": 153.36,
    "bb_lower": 138.64,
    "price_vs_sma20_pct": -3.8,
    "price_vs_sma50_pct": -6.66,
    "volume_ratio": 1.09
  },
  "fundamentals": {
    "market_cap": 488677343232,
    "pe_ratio": 19.578186,
    "forward_pe": 19.134905,
    "price_to_book": 6.1562514,
    "price_to_sales": 5.3031216,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.4,
    "pct_from_52w_low": 44.18
  },
  "macro": {
    "spy": {
      "price": 579.24,
      "change_1d_pct": -2.98,
      "change_7d_pct": -2.74
    },
    "vix": {
      "level": 27.62,
      "signal": "HIGH_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.49
    },
    "dollar_index": {
      "level": 108.03
    },
    "gold": {
      "price": 2636.5
    },
    "regime": "BEAR_HIGH_VOL"
  },
  "news": [
    {
      "headline": "Jim Cramer on Johnson & Johnson (JNJ): How the Pharma Giant is Handling Billion-Dollar Lawsuits and Legal Battles",
      "source": "Yahoo",
      "datetime": 1734551780,
      "summary": "We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discussed recently. As the Federal Reserve exits the year by having continued its interest rat",
      "url": "https://finnhub.io/api/news?id=4134ae3da7f62eaf3602d4dbac5621cfca40d35196db4e336ab3c9d9e9afc3f7"
    },
    {
      "headline": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
      "source": "MarketWatch",
      "datetime": 1734539460,
      "summary": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=802a1a30a94d3dd76cfdee2ae9c1702715552c546297421639a9f6ead4d0a1b8"
    },
    {
      "headline": "Of 63 Fortune500 Industry Leaders, 57 Pay Dividends, 38 Test 'Safer' & 1 Is Ideal To Buy",
      "source": "SeekingAlpha",
      "datetime": 1734531309,
      "summary": "Top 10 Fortune 500 industry leaders show strong yields. See why Energy Transfer\u00e2\u0080\u0099s high-dividend, low-price stock stands out as a safer buy in December.",
      "url": "https://finnhub.io/api/news?id=294dcff3250f20a4f41dbf0edac6759822db14a529fa357fbddcf1120756d296"
    },
    {
      "headline": "SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study",
      "source": "Yahoo",
      "datetime": 1734528060,
      "summary": "Treatment with a Sanofi-Teva-partnered experimental drug meets the primary goals in a mid-stage study for Ulcerative colitis and Crohn's disease indications.",
      "url": "https://finnhub.io/api/news?id=c3dbdf52256b0c9b2a2a05ed9a878d078889a8162d22f3186a8fdd21ae230695"
    },
    {
      "headline": "Tessera gets sickle cell funding; Corvus shares slide on eczema data",
      "source": "Yahoo",
      "datetime": 1734522300,
      "summary": "The Bill & Melinda Gates Foundation will invest up to $50 million in Tessera\u2019s in vivo sickle cell therapy. Elsewhere, Cara agreed to a reverse merger and J&J had a drug application rejected.",
      "url": "https://finnhub.io/api/news?id=52cf94ebb37cb8d7c0bbb601f5e7ffae823ea73b57caa3ce4199c0f573e20814"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734042449.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/xslF345X05/wk-form4_1734042449.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041779.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/xslF345X05/wk-form4_1734041779.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041373.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/xslF345X05/wk-form4_1734041373.xml"
    },
    {
      "form": "13F-HR",
      "date": "2024-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "10-Q",
      "date": "2024-10-23",
      "description": "jnj-20240929.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/jnj-20240929.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}